Drug shortage
Amantadine Hydrochloride Tablet · Upsher-Smith Laboratories, LLC
FDA drug shortage · To Be Discontinued · updated Jul 23, 2025
Key facts
| Generic name | Amantadine Hydrochloride Tablet |
|---|---|
| Company | Upsher-Smith Laboratories, LLC |
| Presentation | Amantadine Hydrochloride, Tablet, 100 mg (NDC 0832-0111-03) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Antiviral Neurology |
| Package NDCs | 0832-0111-03 |
| First posted | Jul 23, 2025 |
| Last updated | Jul 23, 2025 |
| Discontinued | Jul 23, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: